Anbio Biotechnology Class A Ordinary Shares (NNNN)

About NNNN

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen r…

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Employees

27

Website

anbiobiotechnology.com/

Fundamentals

1-day range

$7.35$7.92

Market cap

$1.53B

P/E (trailing)

144.72

P/E (forward)

—

EPS (trailing)

$0.23

Dividend yield

—

Beta

1.53

Avg. volume

81.2K

Anbio Biotechnology Class A Ordinary Shares Competitors

Chosen by industry and closest market cap.

• NNNN

  Anbio Biotechnology Class A Ordinary Shares

  $7.64

  ▼ 1.80%
  Market cap $1.53BP/E 144.72
  $6.61$51.33
• NTLA

  Intellia Therapeutics Inc. Common Stock

  $12.87

  ▼ 1.83%
  Market cap $1.50BP/E —
  $7.95$28.25
• ACHV

  Achieve Life Sciences Inc. Common Shares

  $8.09

  ▼ 1.16%
  Market cap $648.81MP/E —
  $2.62$8.61
• NEOG

  Neogen Corporation Common Stock

  $11.67

  ▼ 0.60%
  Market cap $2.59BP/E —
  $4.9$12.85
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $284.15MP/E —
  $1.91$7.84
• IMDX

  Insight Molecular Diagnostics Inc. Common Stock

  $4.16

  ▼ 3.03%
  Market cap $162.42MP/E —
  $2.33$8.51
• CDIO

  Cardio Diagnostics Holdings Inc. Common stock

  $1.84

  ▼ 1.60%
  Market cap $4.85MP/E —
  $0.97$7.91

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday
  Benzinga · 8/17/2026
• 12 Health Care Stocks Moving In Monday's Pre-Market Session
  Benzinga · 8/17/2026